文献速递血管炎

大动脉炎损伤评估:TADS与VDI的对比研究

Assessment of damage in Takayasu's arteritis.
PubMed 文献 · Semin Arthritis Rheum · 2020-05-14

TADS捕获的疾病相关条目更多(8项 vs 4项),VDI更擅长反映治疗相关损伤。症状起始年龄、病程和累积糖皮质激素剂量与更高损伤评分相关,复发次数与损伤评分无关。

要点

  • VDI更擅长捕获治疗相关损伤,TADS提供疾病相关损伤的补充信息。
  • 症状起始年龄和累积糖皮质激素剂量是VDI≥5的预测因素。
  • 症状起始年龄和病程与TADS≥8的增加相关,复发次数与损伤评分无关。

核心结论

  • VDI似乎更擅长捕获治疗相关损伤,而TADS为大动脉炎的疾病相关损伤提供了一些补充信息。
  • 症状起始年龄较大、病程和累积糖皮质激素剂量与更高的损伤评分相关。
  • 在常规随访的大动脉炎患者中,复发频率不影响损伤水平。

研究设计与样本

  • 在诊断时和随访结束时分别测定大动脉炎损伤评分(TADS)和血管炎损伤指数(VDI),并评估与损伤评分相关的变量。

主要发现

  • 基线时VDI中位评分为4.0(1-8),TADS中位评分为7.0(1-15)。
  • 随访结束时VDI中位评分增至5.0(1-17),TADS中位评分增至8.0(1-19)。
  • TADS中疾病相关条目的中位数量高于VDI(8项 vs 4项)。
  • 35例患者(31%)出现至少一项新的糖皮质激素相关损伤条目。
  • 症状起始年龄和累积糖皮质激素剂量是更高VDI评分(≥5)的预测因素,而症状起始年龄和病程与TADS增加(≥8)相关。

关键数值与推荐

  • 诊断时平均年龄为35.3±13.3岁,基线就诊时症状持续时间中位数为12(0-360)个月,平均随访时间为76.9±51.4个月。
  • VDI≥5和TADS≥8分别作为更高损伤评分的阈值用于分析预测因素。

临床怎么用

  • 在大动脉炎常规随访中可联合使用VDI和TADS,以分别评估治疗相关损伤和疾病相关损伤。
  • 对于症状起始年龄较大、病程较长或累积糖皮质激素剂量较高的患者,应关注更高损伤风险。

局限性

  • 本研究为回顾性设计。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the progression and the factors associated with damage in Takayasu's arteritis (TAK) patients during routine follow-up. METHODS: Patients diagnosed with TAK and had >6 months follow-up were enrolled in this study retrospectively. Takayasu's arteritis damage score (TADS) and vasculitis damage index (VDI) were determined at diagnosis and at the end of the follow-up and variables associated with damage scores were assessed. RESULTS: One-hundred fourteen patients (F/M: 101/13) were included in the study. The mean age at diagnosis, median symptom duration at baseline visit and mean follow-up duration were 35.3±13.3 years, 12 (0-360) months and 76.9±51.4 months, respectively. Median VDI score was 4.0 (1-8) and median TADS score was 7.0 (1-15) at baseline assessment. At the end of the follow-up, median VDI score increased to 5.0 (1-17) and TADS score to 8.0 (1-19). The median number of disease-related items were higher in TADS (8 items vs 4 items). At least one new corticosteroid (CS)-related damage item occurred in 35 patients (31%). Age at symptom-onset and cumulative CS doses were predictor factors for higher VDI score (≥5), whereas age at symptom-onset and disease duration were associated with increase in TADS (≥8). Gender and number of relapses were not associated with damage scores. CONCLUSION: Damage assessment with VDI seems to capture treatment-related damage better, whereas TADS provides some additional information on disease-related damage in Takayasu's arteritis. Older age at symptom onset, disease duration and cumulative CS dose were associated with higher damage scores. The relapse frequency did not influence the damage level in our routine-follow-up of TAK patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Kaymaz-Tahra S, Alibaz-Oner F, Direskeneli H, et al. Assessment of damage in Takayasu's arteritis. Semin Arthritis Rheum. 2020. PMID: 32470706. doi:10.1016/j.semarthrit.2020.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。